Results 11 to 20 of about 31,287 (200)

Incorporation of thymidine into onion root meristematic cell nuclei in presence of hydroxyurea and its role in recovery of mitotic activity

open access: yesActa Societatis Botanicorum Poloniae, 2015
Hydroxyurea treatment of onion roots induced mitotic block which was released by transfer of bulbs to water, and also to some extent by addition of cold or 3H-thymidine to hydroxyurea solutions.
H. Habdas
doaj   +1 more source

Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythemia Vera: A Multicenter Chart Review Study

open access: yesTurkish Journal of Hematology, 2020
Objective: This study aimed to evaluate real-life data on patterns of hydroxyurea prescription/use in polycythemia vera (PV). Materials and Methods: This retrospective chart review study included PV patients who had received hydroxyurea therapy for at ...
Yahya Büyükaşık   +20 more
doaj   +1 more source

Do Genetic Polymorphisms Affect Fetal Hemoglobin (HbF) Levels in Patients With Sickle Cell Anemia Treated With Hydroxyurea? A Systematic Review and Pathway Analysis

open access: yesFrontiers in Pharmacology, 2022
Hydroxyurea has long been used for the treatment of sickle cell anemia (SCA), and its clinical effectiveness is related to the induction of fetal hemoglobin (HbF), a major modifier of SCA phenotypes.
Rahyssa Rodrigues Sales   +5 more
doaj   +1 more source

Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study

open access: yesJMIR Research Protocols, 2020
BackgroundHydroxyurea prevents disease complications among patients with sickle cell disease (SCD). Although its efficacy has been endorsed by the National Health Lung and Blood Institute evidence-based guidelines, its adoption is low, both by patients ...
Hankins, Jane S   +17 more
doaj   +1 more source

Adherence to hydroxyurea, health-related quality of life domains, and patients’ perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults

open access: yesHealth and Quality of Life Outcomes, 2017
Background Sickle cell disease (SCD) patients have impaired domains of health-related quality of life (HRQOL). Hydroxyurea is safe and efficacious in SCD; however, adherence is suboptimal, and patients’ perceptions are poorly understood amongst ...
Sherif M. Badawy   +5 more
doaj   +1 more source

Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea

open access: yesHaematologica, 2017
Hematocrit control below 45% is associated with a lower rate of thrombosis in polycythemia vera. In patients receiving hydroxyurea, this target can be achieved with hydroxyurea alone or with the combination of hydroxyurea plus phlebotomies.
Alberto Alvarez-Larrán   +28 more
doaj   +1 more source

Class 1 Histone Deacetylases and Ataxia-Telangiectasia Mutated Kinase Control the Survival of Murine Pancreatic Cancer Cells upon dNTP Depletion

open access: yesCells, 2021
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive disease with a dismal prognosis. Here, we show how an inhibition of de novo dNTP synthesis by the ribonucleotide reductase (RNR) inhibitor hydroxyurea and an inhibition of epigenetic ...
Alexandra Nguyen   +5 more
doaj   +1 more source

Hydroxyurea associated ileocecal valve ulcer: evidence for causality [PDF]

open access: yesIntestinal Research, 2021
Hydroxyurea is an antimetabolite drug that is commonly used in many hematological disorders. Ulcer formation in the gastrointestinal tract is a rare phenomenon associated with this drug.
Thevaraajan Jayaraman   +3 more
doaj   +1 more source

Studies with Hydroxyurea VII. Hydroxyurea and the Synthesis of Functional Proteins [PDF]

open access: yesJournal of Bacteriology, 1967
Hydroxyurea affected neither the synthesis nor the degradation of bacterial messenger-ribonucleic acid. The proteins made by hydroxyurea-treated cells were structurally intact and fully functional. Since the expression of the lethal action of hydroxyurea requires active protein production, the data indicate that treated cells do not die as the result ...
H S, Rosenkranz   +4 more
openaire   +2 more sources

Photodermatosis secondary to hydroxyurea [PDF]

open access: yesBMJ Case Reports, 2014
A middle aged Southeast-Asian man, recently diagnosed with chronic myeloid leukaemia (Philadelphia positive on FISH), was started on cytoreductive therapy with hydroxyurea due to high leucocyte count (130 000/µL). The patient had no history of using any other drugs simultaneously or in the recent/remote past. He developed a clearly defined erythematous
Uday, Yanamandra   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy